Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity

Research output: Contribution to journalReview article

Abstract

Purpose of Review: There are multiple pharmacological and psychosocial interventions that are tolerable and efficacious for the treatment of attention deficit hyperactivity disorder (ADHD). However, many youth with ADHD have elevated levels of mood and anxiety symptoms that can complicate treatment. In this review, we summarize the relevant treatment studies on the treatment of youth with ADHD and comorbid anxiety or mood disorders. Recent Findings: Treatment of ADHD, specifically CNS stimulants, often translates to reduced irritability in youth with ADHD, but appears to have limited impact on other mood or anxiety symptoms. The presence of ADHD does not appear to reduce the efficacy of pharmacological treatments of mood and anxiety disorders. There is less data on the impact of ADHD on psychosocial treatments for internalizing disorders. Summary: In children with elevated levels of mood or anxiety, ADHD can be safely and effectively treated with either evidence-based pharmacological or psychosocial interventions. However, additional treatments are often needed to achieve significant improvements in other mood or anxiety symptoms.

Original languageEnglish (US)
Pages (from-to)73-97
Number of pages25
JournalCurrent Treatment Options in Psychiatry
Volume5
Issue number1
DOIs
StatePublished - Mar 1 2018

Fingerprint

Attention Deficit Disorder with Hyperactivity
Comorbidity
Anxiety
Pharmacology
Therapeutics
Anxiety Disorders
Mood Disorders

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

@article{5d0a07011b354f25bb20f71da5da7f4b,
title = "Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity",
abstract = "Purpose of Review: There are multiple pharmacological and psychosocial interventions that are tolerable and efficacious for the treatment of attention deficit hyperactivity disorder (ADHD). However, many youth with ADHD have elevated levels of mood and anxiety symptoms that can complicate treatment. In this review, we summarize the relevant treatment studies on the treatment of youth with ADHD and comorbid anxiety or mood disorders. Recent Findings: Treatment of ADHD, specifically CNS stimulants, often translates to reduced irritability in youth with ADHD, but appears to have limited impact on other mood or anxiety symptoms. The presence of ADHD does not appear to reduce the efficacy of pharmacological treatments of mood and anxiety disorders. There is less data on the impact of ADHD on psychosocial treatments for internalizing disorders. Summary: In children with elevated levels of mood or anxiety, ADHD can be safely and effectively treated with either evidence-based pharmacological or psychosocial interventions. However, additional treatments are often needed to achieve significant improvements in other mood or anxiety symptoms.",
author = "Raman Baweja and Waxmonsky, {James G.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1007/s40501-018-0135-3",
language = "English (US)",
volume = "5",
pages = "73--97",
journal = "Current Treatment Options in Psychiatry",
issn = "2196-3061",
publisher = "Springer International Publishing AG",
number = "1",

}

Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity. / Baweja, Raman; Waxmonsky, James G.

In: Current Treatment Options in Psychiatry, Vol. 5, No. 1, 01.03.2018, p. 73-97.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity

AU - Baweja, Raman

AU - Waxmonsky, James G.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose of Review: There are multiple pharmacological and psychosocial interventions that are tolerable and efficacious for the treatment of attention deficit hyperactivity disorder (ADHD). However, many youth with ADHD have elevated levels of mood and anxiety symptoms that can complicate treatment. In this review, we summarize the relevant treatment studies on the treatment of youth with ADHD and comorbid anxiety or mood disorders. Recent Findings: Treatment of ADHD, specifically CNS stimulants, often translates to reduced irritability in youth with ADHD, but appears to have limited impact on other mood or anxiety symptoms. The presence of ADHD does not appear to reduce the efficacy of pharmacological treatments of mood and anxiety disorders. There is less data on the impact of ADHD on psychosocial treatments for internalizing disorders. Summary: In children with elevated levels of mood or anxiety, ADHD can be safely and effectively treated with either evidence-based pharmacological or psychosocial interventions. However, additional treatments are often needed to achieve significant improvements in other mood or anxiety symptoms.

AB - Purpose of Review: There are multiple pharmacological and psychosocial interventions that are tolerable and efficacious for the treatment of attention deficit hyperactivity disorder (ADHD). However, many youth with ADHD have elevated levels of mood and anxiety symptoms that can complicate treatment. In this review, we summarize the relevant treatment studies on the treatment of youth with ADHD and comorbid anxiety or mood disorders. Recent Findings: Treatment of ADHD, specifically CNS stimulants, often translates to reduced irritability in youth with ADHD, but appears to have limited impact on other mood or anxiety symptoms. The presence of ADHD does not appear to reduce the efficacy of pharmacological treatments of mood and anxiety disorders. There is less data on the impact of ADHD on psychosocial treatments for internalizing disorders. Summary: In children with elevated levels of mood or anxiety, ADHD can be safely and effectively treated with either evidence-based pharmacological or psychosocial interventions. However, additional treatments are often needed to achieve significant improvements in other mood or anxiety symptoms.

UR - http://www.scopus.com/inward/record.url?scp=85062817708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062817708&partnerID=8YFLogxK

U2 - 10.1007/s40501-018-0135-3

DO - 10.1007/s40501-018-0135-3

M3 - Review article

AN - SCOPUS:85062817708

VL - 5

SP - 73

EP - 97

JO - Current Treatment Options in Psychiatry

JF - Current Treatment Options in Psychiatry

SN - 2196-3061

IS - 1

ER -